Linde stock pairs stronger guidance with restructuring focus

Published on 11/04/2026 at 17:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Linde stock enters November with stronger earnings guidance and record quarterly sales. Restructuring at Lincare keeps execution in focus for investors.

Growth Meets Execution Questions

Linde lifted its full-year adjusted earnings outlook after record third-quarter sales and adjusted earnings.
A 425 million US dollar restructuring charge and changes at Lincare add execution risk for investors.
Electronics demand, a strong project backlog and planned capital spending support the growth outlook.

Linde, IE000S9YS762, Illustration mit AI erstellt.

Linde reported record third-quarter sales and adjusted earnings on Thursday, October 29, 2026, while raising its full-year adjusted earnings outlook. The company also disclosed restructuring measures affecting its Lincare home-care business, adding an execution issue to an otherwise stronger operating picture, according to Linde's third-quarter results release.

Record Quarter Raises Outlook

Sales rose 9 percent year over year to 9.404 billion US dollars, while underlying sales increased 5 percent. Price attainment contributed 3 percentage points and volume growth contributed 2 percentage points, with electronics, chemicals and energy, and manufacturing among the main end markets.

Adjusted diluted earnings per share increased 9 percent to 4.59 US dollars. Adjusted operating profit rose 8 percent to 2.763 billion US dollars, producing an adjusted operating margin of 29.4 percent. Operating cash flow advanced 8 percent to 3.169 billion US dollars, and free cash flow after capital expenditure reached 1.777 billion US dollars.

The reported figures were weaker. Net income was 1.692 billion US dollars and diluted earnings per share fell 11 percent to 3.66 US dollars. Linde said the adjusted figures excluded purchase-accounting effects, cost-reduction charges and other items, making the distinction important when assessing the quality of earnings growth.

Restructuring Adds Execution Risk

Linde raised its 2026 adjusted diluted earnings guidance to 17.82 to 17.92 US dollars per share, implying growth of 8 to 9 percent. Fourth-quarter adjusted earnings are expected at 4.40 to 4.50 US dollars per share, or growth of 5 to 7 percent from the prior-year quarter. Planned full-year capital expenditure stands at 5.5 billion to 6.0 billion US dollars.

The company took a 425 million US dollar restructuring charge during the quarter, with roughly half related to severance and much of the remainder linked to Lincare actions. Management is moving Lincare under Chief Financial Officer Matt White and evaluating strategic alternatives, steps intended to improve visibility into the regional gases operations.

Linde stock traded at 466.30 euros on Lang & Schwarz at 17:38 CET on Wednesday, November 4, 2026. Investors can follow the real-time quote of Linde stock.